Anne Montgomery (@BPI_Anne) header
Anne Montgomery (@BPI_Anne) profile picture

Anne Montgomery

@BPI_Anne

BioProcess International magazine editor in chief -- always looking for hot topics and people eager to write about them!

 Oregon, USA
Joined July 2016
  • Tweets208
  • Following206
  • Followers180
3Media
Photo by Anne Montgomery (@BPI_Anne)Photo by Anne Montgomery (@BPI_Anne)
An unexpected discovery turns into a useful tool for #CRISPR technology .@AprilPawluk .@UofT .@lnhandly ow.ly/cAQo308R2dU
Image from BioTechniques (@MyBioTechniques)
12
8
Anne Montgomery retweeted
Lonza Drug Product (@LonzaDPS) profile picture
Lonza Drug Product@LonzaDPS11 Apr 2017
#LonzaDrugProduct expert M. Jahn featured in @BioProcessIntl ebook on Extractables & Leachables. Read ebook here: ow.ly/nmkt30aJW0U
Image from Lonza Drug Product (@LonzaDPS)
1
1
1
Anne Montgomery retweeted
Amgen 🧪🔬🧬 (@Amgen) profile picture
Amgen 🧪🔬🧬
@Amgen11 Apr 2017
This month, we’re busting the craziest #cholesterol and #heartdisease myths to help show healthy lifestyle tips! #AmgenCV
5
8
1
8
Anne Montgomery retweeted
EBD Group (@EBDgroup) profile picture
EBD Group@EBDgroup6 Mar 2017
Access a world of opportunities at our premier springtime partnering conference #BIOEuropeSpring REGISTER NOW >> spr.ly/60188pQna
Image from EBD Group (@EBDgroup)
1
Anne Montgomery retweeted
EBD Group (@EBDgroup) profile picture
EBD Group@EBDgroup6 Mar 2017
#BIOEuropeSpring #RareDisease Panel Discussion 🎤 w/ @CriticalOutcome, @CincyChildrens, @CoteOrphan, @GlobalGenes > bit.ly/2lx8VfPc
Image from EBD Group (@EBDgroup)
2
2
The #CRO market in Asia has "massive implications." #clinicaltrials #outsourcing #pharma >> outsourcing-pharma.com/Clini…
Image from Outsourcing-Pharma (@OutsourcPharma)
2
2
Anne Montgomery retweeted
Catalent (@Catalent_) profile picture
Catalent
@Catalent_2 Mar 2017
FDA approves Merck's Odactra, the first allergen extract that is administered sublingually |ow.ly/LYIr309wVPL |ow.ly/1c8T309wVKG
4
2
Another #biosimilar competitor in the making for #Humira: Coherus reports #bioequivalence data. shar.es/1UoQY0
Image from CenterForBiosimilars (@BiosimCenter)
3
RT @GEbioprocess: "No one is doing single use technology because they love plastics. They do it for the outcome". Jeff Carter @ #bpiwest
1
2
2
FACT: There are 7,000 known #rarediseases. Retweet to raise awareness on #RareDiseaseDay!
4
184
12
102
It's about that time again! Looking forward to the opening night of #bpiwest in #SanFrancisco tomorrow!
1
Anne Montgomery retweeted
Bethz Hurst (@bethzhurst) profile picture
Bethz Hurst@bethzhurst22 Feb 2017
Growth Projections for #RegenerativeMedicine goo.gl/3j92kK @Cytomedix @Mesoblast @mfoundation @regensci @regenMD @Bioprocess365
Image from Bethz Hurst (@bethzhurst)
1
Introducing our new Editorial Advisor, Jason Condon from Vaccinex ow.ly/v14s3094AJ0
Image from BioProcess Intl. (@BioProcessIntl)
1
1
View the February issue of BPI - online now ow.ly/VmOK3094zEn #downstreamprocessing
Image from BioProcess Intl. (@BioProcessIntl)
1
1
Incredible stat: vaccines have saved 18,600 kids a *day* for almost 26 years 💉
3
283
30
238
Anne Montgomery retweeted
NIH (@NIH) profile picture
NIH
@NIH14 Feb 2017
There are 6K+ rare diseases affecting 25-30M Americans. @NIHDirector @ORDR @ncats_nih_gov @sharonfterry & more will take your ?s at #NIHchat
Image from NIH (@NIH)
2
33
4
17
What are the risks & consequences of excessive customization in single-use technologies? Find out: ow.ly/t547308MEnH #BioTech #BPIWest
2
2
Anne Montgomery retweeted
EBD Group (@EBDgroup) profile picture
EBD Group@EBDgroup13 Feb 2017
What do current indicators mean for future immuno-oncology deal flow?Jeff Bockman, Defined Health #BIOEuropeSpring bit.ly/2kpB9nE
Image from EBD Group (@EBDgroup)
1
Anne Montgomery retweeted
womenshealth.gov (@womenshealth) profile picture
womenshealth.gov
@womenshealth6 Feb 2017
Diabetes hits women and men in almost equal numbers. But it affects women differently than men. go.usa.gov/x9GRq
11
7
Anne Montgomery retweeted
Lee Buckler (@celltherapy) profile picture
Lee Buckler
@celltherapy6 Feb 2017
FDA is now accepting regenerative therapy applications for RAT designation as defined in the 21st Century Cures Act shar.es/19bArG
1
4
1
Load more